It's a slow day, but I still managed to find at least one 340B link, because I want to stay on-brand
But I have some suggestions for reporters looking for a way to stay busy this week without chasing the same, tired price-increase story
And thank you, President Carter, for teaching us all how much global public health matters
Have a great holiday, everyone!
And thanks to everyone who weighed in on the future of Cost Curve. With that feedback, I'm committed to making 2025 a banner year
And PBM reform seems to be dead. For now. Maybe. (I'm choosing to think that reform is merely pining for the fjords)
Plus Pfizer pulls back the curtain on what the IRA's Part D benefit design change will cost them next year: $1 billion
And I have a survey on the future direction of Cost Curve for you all. I'd be eternally grateful for your feedback.
And 2024 has seen an explosion in great curation and commentary around health policy, and I'm grateful for that
And IQVIA documents the gap between drug approvals in the U.S. and those in Europe
And pieces on how to make our system more value-driven, the fate of PBM reform, and what Oz may do with IRA
